CVS Health Corp
F:CVS

Watchlist Manager
CVS Health Corp Logo
CVS Health Corp
F:CVS
Watchlist
Price: 66.9 EUR 1.07% Market Closed
Market Cap: 84.9B EUR

Intrinsic Value

The intrinsic value of one CVS stock under the Base Case scenario is 137.45 EUR. Compared to the current market price of 66.9 EUR, CVS Health Corp is Undervalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CVS Intrinsic Value
137.45 EUR
Undervaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
CVS Health Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about CVS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CVS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CVS Health Corp.

Explain Valuation
Compare CVS to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

CVS’s pivot into full-scale healthcare services, including the integration of Aetna and recent acquisitions like Signify Health, is stretching the company’s resources and may strain operational efficiency if the synergy benefits take too long to materialize.

Heavier regulatory scrutiny around pharmacy benefit managers (PBMs) poses a direct threat to CVS’s industry-leading Caremark, potentially constraining profit margins and prompting costly compliance measures that could neutralize growth.

With competition from both traditional retailers expanding their pharmacy segments and digital-first disruptors targeting medication delivery and telehealth, CVS risks losing market share if it cannot keep pace with evolving consumer preferences for convenience and online access.

Bull Theses

CVS’s vertically integrated business model—combining retail pharmacy, PBM services, and health insurance under one roof—creates potential for strong cross-selling and cost-saving synergies unmatched by many peers in the healthcare industry.

The company’s HealthHUB strategy transforms select stores into focused healthcare destinations, letting CVS capture higher-margin clinical services revenue and differentiate itself from purely transactional pharmacy competitors.

Strong cash flows from its core retail and PBM segments enable CVS to invest heavily in digital health initiatives and more strategic acquisitions, positioning it to deliver diversified revenue growth over the long term.

Show More Less
How do you feel about CVS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CVS Health Corp

Current Assets 77.1B
Cash & Short-Term Investments 11.2B
Receivables 43.9B
Other Current Assets 22B
Non-Current Assets 178.2B
Long-Term Investments 31.6B
PP&E 28.1B
Intangibles 111.5B
Other Non-Current Assets 7.1B
Current Liabilities 92.7B
Accounts Payable 60.9B
Accrued Liabilities 25.3B
Short-Term Debt 1.2B
Other Current Liabilities 5.2B
Non-Current Liabilities 89.7B
Long-Term Debt 60.5B
Other Non-Current Liabilities 29.2B
Efficiency

Free Cash Flow Analysis
CVS Health Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CVS Health Corp

Revenue
394.1B USD
Cost of Revenue
-339.4B USD
Gross Profit
54.7B USD
Operating Expenses
-43.9B USD
Operating Income
10.8B USD
Other Expenses
-10.3B USD
Net Income
469m USD
Fundamental Scores

CVS Profitability Score
Profitability Due Diligence

CVS Health Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Net Margin
Declining Gross Margin
42/100
Profitability
Score

CVS Health Corp's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

CVS Solvency Score
Solvency Due Diligence

CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
33/100
Solvency
Score

CVS Health Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CVS Price Targets Summary
CVS Health Corp

Wall Street analysts forecast CVS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVS is 80.7 EUR with a low forecast of 67.87 EUR and a high forecast of 93.46 EUR.

Lowest
Price Target
67.87 EUR
1% Upside
Average
Price Target
80.7 EUR
21% Upside
Highest
Price Target
93.46 EUR
40% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CVS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CVS Insider Trading
Buy and sell transactions by insiders

CVS News

Other Videos
What is the Intrinsic Value of one CVS stock?

The intrinsic value of one CVS stock under the Base Case scenario is 137.45 EUR.

Is CVS stock undervalued or overvalued?

Compared to the current market price of 66.9 EUR, CVS Health Corp is Undervalued by 51%.

Back to Top